115 related articles for article (PubMed ID: 9813235)
1. Flavin-containing monooxygenase mediated metabolism of benzydamine in perfused brain and liver.
Kawaji A; Isobe M; Tochino Y; Takabatake E; Chikaoka Y; Nomura Y; Tamura M
Biochim Biophys Acta; 1998 Sep; 1425(1):41-6. PubMed ID: 9813235
[TBL] [Abstract][Full Text] [Related]
2. Determination of flavin-containing monooxygenase activity in rat brain microsomes with benzydamine N-oxidation.
Kawaji A; Ohara K; Takabatake E
Biol Pharm Bull; 1994 May; 17(5):603-6. PubMed ID: 7920416
[TBL] [Abstract][Full Text] [Related]
3. An assay of flavin-containing monooxygenase activity with benzydamine N-oxidation.
Kawaji A; Ohara K; Takabatake E
Anal Biochem; 1993 Nov; 214(2):409-12. PubMed ID: 8109727
[TBL] [Abstract][Full Text] [Related]
4. Assessment of benzydamine N-oxidation mediated by flavin-containing monooxygenase in different regions of rat brain and liver using microdialysis.
Kawaji A; Yamaguchi T; Tochino Y; Isobe M; Takabatake E
Biol Pharm Bull; 1999 Jan; 22(1):1-4. PubMed ID: 9989652
[TBL] [Abstract][Full Text] [Related]
5. Benzydamine N-oxygenation as an index for flavin-containing monooxygenase activity and benzydamine N-demethylation by cytochrome P450 enzymes in liver microsomes from rats, dogs, monkeys, and humans.
Taniguchi-Takizawa T; Shimizu M; Kume T; Yamazaki H
Drug Metab Pharmacokinet; 2015 Feb; 30(1):64-9. PubMed ID: 25760531
[TBL] [Abstract][Full Text] [Related]
6. Benzydamine N-oxidation as an index reaction reflecting FMO activity in human liver microsomes and impact of FMO3 polymorphisms on enzyme activity.
Störmer E; Roots I; Brockmöller J
Br J Clin Pharmacol; 2000 Dec; 50(6):553-61. PubMed ID: 11136294
[TBL] [Abstract][Full Text] [Related]
7. Differences in enzymatic properties of flavin-containing monooxygenase in brain microsomes of rat, mouse, hamster, guinea pig and rabbit.
Kawaji A; Isobe M; Takabatake E
Biol Pharm Bull; 1997 Aug; 20(8):917-9. PubMed ID: 9300142
[TBL] [Abstract][Full Text] [Related]
8. Flavin-containing monooxygenase activity in hepatocytes and microsomes: in vitro characterization and in vivo scaling of benzydamine clearance.
Fisher MB; Yoon K; Vaughn ML; Strelevitz TJ; Foti RS
Drug Metab Dispos; 2002 Oct; 30(10):1087-93. PubMed ID: 12228184
[TBL] [Abstract][Full Text] [Related]
9. In vitro evaluation of potential in vivo probes for human flavin-containing monooxygenase (FMO): metabolism of benzydamine and caffeine by FMO and P450 isoforms.
Lang DH; Rettie AE
Br J Clin Pharmacol; 2000 Oct; 50(4):311-4. PubMed ID: 11012553
[TBL] [Abstract][Full Text] [Related]
10. Benzydamine as a useful substrate of hepatic flavin-containing monooxygenase activity in veterinary species.
Capolongo F; Santi A; Anfossi P; Montesissa C
J Vet Pharmacol Ther; 2010 Aug; 33(4):341-6. PubMed ID: 20646194
[TBL] [Abstract][Full Text] [Related]
11. Further characterization of rat brain flavin-containing monooxygenase. Metabolism of imipramine to its N-oxide.
Bhagwat SV; Bhamre S; Boyd MR; Ravindranath V
Biochem Pharmacol; 1996 Jun; 51(11):1469-75. PubMed ID: 8630088
[TBL] [Abstract][Full Text] [Related]
12. Estimation of flavin-containing monooxygenase activity in intact hepatocyte monolayers of rat, hamster, rabbit, dog and human by using N-oxidation of benzydamine.
Ubeaud G; Schiller CD; Hurbin F; Jaeck D; Coassolo P
Eur J Pharm Sci; 1999 Aug; 8(4):255-60. PubMed ID: 10425375
[TBL] [Abstract][Full Text] [Related]
13. Partial purification and substrate specificity of flavin-containing monooxygenase from rat brain microsomes.
Kawaji A; Miki T; Takabatake E
Biol Pharm Bull; 1995 Dec; 18(12):1657-9. PubMed ID: 8787783
[TBL] [Abstract][Full Text] [Related]
14. Hepatic Flavin-containing Monooxygenase and Aldehyde Oxidase Activities in Male Domestic Pigs at Different Ages.
Hu SX
Drug Metab Lett; 2018; 12(2):125-131. PubMed ID: 30215338
[TBL] [Abstract][Full Text] [Related]
15. Benzydamine N-oxygenation as a measure of flavin-containing monooxygenase activity.
Yeung CK; Rettie AE
Methods Mol Biol; 2006; 320():157-62. PubMed ID: 16719388
[TBL] [Abstract][Full Text] [Related]
16. Flavin-containing monooxygenase activity in camel tissues: comparison with rat and human liver enzymes.
Raza H; Bhagwat SV; John A
Comp Biochem Physiol C Toxicol Pharmacol; 2004 Dec; 139(4):289-93. PubMed ID: 15683840
[TBL] [Abstract][Full Text] [Related]
17. Drug oxygenation activities mediated by liver microsomal flavin-containing monooxygenases 1 and 3 in humans, monkeys, rats, and minipigs.
Yamazaki M; Shimizu M; Uno Y; Yamazaki H
Biochem Pharmacol; 2014 Jul; 90(2):159-65. PubMed ID: 24821112
[TBL] [Abstract][Full Text] [Related]
18. Metabolism of dipropyl disulfide by rat liver phase I and phase II enzymes and by isolated perfused rat liver.
Teyssier C; Siess MH
Drug Metab Dispos; 2000 Jun; 28(6):648-54. PubMed ID: 10820136
[TBL] [Abstract][Full Text] [Related]
19. Human plasma metabolic profiles of benzydamine, a flavin-containing monooxygenase probe substrate, simulated with pharmacokinetic data from control and humanized-liver mice.
Yamazaki-Nishioka M; Shimizu M; Suemizu H; Nishiwaki M; Mitsui M; Yamazaki H
Xenobiotica; 2018 Feb; 48(2):117-123. PubMed ID: 28145791
[TBL] [Abstract][Full Text] [Related]
20. Cerebral metabolism of imipramine and a purified flavin-containing monooxygenase from human brain.
Bhagwat SV; Bhamre S; Boyd MR; Ravindranath V
Neuropsychopharmacology; 1996 Aug; 15(2):133-42. PubMed ID: 8840349
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
